TY - JOUR T1 - Hospital admissions for bronchiolitis in preterm infants in the absence of respiratory syncytial virus prophylaxis JF - Archives of Disease in Childhood - Fetal and Neonatal Edition JO - Arch Dis Child Fetal Neonatal Ed SP - F92 LP - F92 DO - 10.1136/adc.2003.036012 VL - 90 IS - 1 AU - P Bala AU - C A Ryan AU - B P Murphy Y1 - 2005/01/01 UR - http://fn.bmj.com/content/90/1/F92.1.abstract N2 - Respiratory syncytial virus (RSV) is the causative agent in more than 50% of cases of bronchiolitis, with mycoplasma pneumonia, Para influenza 3, adenovirus, and some other viruses accounting for most of the remaining cases. Mortality from bronchiolitis ranges from 1% to 3%. Although as yet there is no safe and effective vaccine, passive immunity with Palivizumab has been shown to reduce hospital admissions of preterm babies, but no reduction in mortality, intensive care admissions, or ventilation days was observed.1 Critical appraisal of this study reveals that the number of infants to … ER -